PrepTutorEJDIC
- =prohibitive
English Journal
- Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study 0229N.
- Makker V1, Filiaci VL2, Chen LM3, Darus CJ4, Kendrick JE5, Sutton G6, Moxley K7, Aghajanian C8.
- Gynecologic oncology.Gynecol Oncol.2015 Apr 16. pii: S0090-8258(15)00796-9. doi: 10.1016/j.ygyno.2015.04.006. [Epub ahead of print]
- OBJECTIVE: This two-stage phase II study assessed activity of single agent dalantercept in patients with recurrent/persistent endometrial carcinoma (EMC).METHODS: Eligible patients had persistent/recurrent EMC after 1-2 prior cytotoxic regimens, measurable disease (RECIST 1.1), and GOG performance�
- PMID 25888978
- The diagnostic value of adiponectin multimers in healthy men undergoing screening for prostate cancer.
- Medina EA1, Shi X, Grayson MH, Ankerst DP, Livi CB, Medina MV, Thompson IM Jr, Leach RJ.
- Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.Cancer Epidemiol Biomarkers Prev.2014 Feb;23(2):309-15. doi: 10.1158/1055-9965.EPI-13-0574. Epub 2013 Dec 2.
- BACKGROUND: Adiponectin has been reported to have a prohibitory effect on prostate cancer. The goal of this study was to evaluate the diagnostic value of adiponectin multimers for prostate cancer.METHODS: Total adiponectin, high- and low-molecular-weight (HMW, LMW), ratios of these measures, and bod
- PMID 24296854
- Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
- Alvarez EA1, Brady WE, Walker JL, Rotmensch J, Zhou XC, Kendrick JE, Yamada SD, Schilder JM, Cohn DE, Harrison CR, Moore KN, Aghajanian C.
- Gynecologic oncology.Gynecol Oncol.2013 Apr;129(1):22-7. doi: 10.1016/j.ygyno.2012.12.022. Epub 2012 Dec 20.
- OBJECTIVE: This two-stage phase II study was designed to assess the activity of the combination of temsirolimus and bevacizumab in patients with recurrent or persistent endometrial carcinoma (EMC).METHODS: Eligible patients had persistent or recurrent EMC after receiving 1-2 prior cytotoxic regimens
- PMID 23262204
Japanese Journal
- 木曽山における森林保護と巣山・留山再考--尾張藩の享保林政改革前を中心に
- 大崎 晃
- 徳川林政史研究所研究紀要 (41), 23-49, 2007-03
- NAID 40015473464
- 八齋戒とその功徳(第六部会,<特集>第六十四回学術大会紀要)
- 龍口 明生
- 宗教研究 79(4), 1189-1190, 2006-03-30
- NAID 110004752171
- 浄土教と戒
- 龍口 明生
- 印度學佛教學研究 54(2), 642-648, 2006-03-20
- NAID 110004708420
Related Links
- pro·hib·i·tive (pr -h b -t v) also pro·hib·i·to·ry (-tôr , -t r ). adj. 1. Prohibiting; forbidding: took prohibitive measures. 2. So high or burdensome as to discourage purchase or use: prohibitive prices. 3. So likely to win as to discourage competition: the ...
Related Pictures
